July 1, 2024 – Page 7 – Goldea Capital

Connect Biopharma to Participate in the Leerink Partners I&I and Metabolism Therapeutics Forum

Written by Customer Service on July 1, 2024. Posted in Public Companies.

SAN DIEGO, CA and TIACANG, China, July 01, 2024 (GLOBE NEWSWIRE) — Connect Biopharma Holdings Limited (Nasdaq: CNTB) (Connect or the Company), a U.S.-headquartered, global clinical-stage biopharmaceutical company dedicated to improving the lives of patients with chronic inflammatory diseases through the development of therapies derived from T cell-driven research, announced today that Barry Quart, Chief Executive Officer, David Szekeres, President and Steven Chan, Chief Financial officer will be hosting one-on-one investor meetings at the Leerink Partners Inflammation and Immunology (I&I) and Metabolism Therapeutics Forum, taking place on July 9-10, 2024 in Boston, MA. About Connect Biopharma Holdings Limited Connect Biopharma is a global, clinical-stage biopharmaceutical company applying its expertise in T cell biology and...

Tonix Pharmaceuticals Awarded Up to $34 Million U.S. Department of Defense Contract for Accelerated Development of Broad-Spectrum Antiviral Program

Written by Customer Service on July 1, 2024. Posted in Public Companies.

Defense Threat Reduction Agency (DTRA) contract is expected to advance development of Tonix’s broad-spectrum oral antiviral program TNX-4200 for medical countermeasures CHATHAM, N.J., July 01, 2024 (GLOBE NEWSWIRE) — Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) (Tonix or the Company), a fully-integrated biopharmaceutical company with marketed products and a pipeline of development candidates, today announced it has been awarded an Other Transaction Agreement (OTA) with a potential for up to $34 million over five years by the Defense Threat Reduction Agency (DTRA), an agency within the U.S. Department of Defense (DoD). The objective of the contract is to develop small molecule broad-spectrum antiviral agents for the prevention or treatment of infections to improve the medical readiness of military personnel in biological threat...

Japan’s APRESIA Systems Expands Access Network Solutions Portfolio with Integration of Infinera ICE-X Coherent Pluggables

Written by Customer Service on July 1, 2024. Posted in Public Companies.

SAN JOSE, Calif., July 01, 2024 (GLOBE NEWSWIRE) — Infinera (Nasdaq: INFN) announced today it is expanding its partnership with APRESIA Systems, Ltd. (APRESIA), a Japanese provider of network infrastructure solutions, through the integration of Infinera’s software-programmable ICE-X coherent pluggables into APRESIA’s portfolio of locally manufactured Layer 2/3 switching and optical transmission products. Infinera’s ICE-X coherent pluggables will enable APRESIA to enhance its access network solutions and offer its customers increased operational value, including new revenue-generating services, reduced CapEx and OpEx, and maximized utilization of fiber assets. APRESIA, an Infinera resale partner in Japan and member of the Open XR Optics Forum, will leverage the XR optics-enabled capabilities of Infinera’s ICE-X pluggables to address...

Gentex Schedules Second Quarter 2024 Earnings Release Date and Conference Call

Written by Customer Service on July 1, 2024. Posted in Public Companies.

ZEELAND, Mich., July 01, 2024 (GLOBE NEWSWIRE) — Gentex Corporation (NASDAQ: GNTX), the Zeeland, Michigan-based supplier of digital vision, connected car, dimmable glass, and fire protection technologies, is pleased to announce that it will release its second quarter 2024 financial results on Friday, July 26, before the market opens. The Company will host a conference call for the investment community at 9:30am ET to discuss the results. The call will also be available to the general public via a live audio webcast. Participants who wish to ask questions may register for the call at the following URL to receive the dial-in numbers and unique PIN: https://register.vevent.com/register/BIf7fb8a2d1c3548749b75c0f597d02049. It is recommended that participants join 10 minutes prior to the event start, although they may register ahead...

Envoy Medical Announces Inclusion in the Russell Microcap Index

Written by Customer Service on July 1, 2024. Posted in Public Companies.

WHITE BEAR LAKE, MN, July 01, 2024 (GLOBE NEWSWIRE) — Envoy Medical®, Inc. (“Envoy Medical”) (Nasdaq: COCH), a revolutionary hearing health company focused on fully implanted hearing systems, announces that FTSE Russell has selected the Company’s shares for inclusion in its Microcap Index. The inclusion became effective at the close of market on Friday, June 28, 2024. The Russell Microcap® Index measures the performance of the microcap segment of the US equity market. A wide range of microcap ETFs follow this benchmark and may reweight their holdings over the coming weeks for changes that occurred in this Index effective as of June 28. “Our addition to the Russell Microcap Index is another important step in building more awareness about Envoy Medical and the potential high-growth opportunity ahead with our fully implanted hearing...

Arteris Joins Russell 2000® Index

Written by Customer Service on July 1, 2024. Posted in Public Companies.

CAMPBELL, Calif., July 01, 2024 (GLOBE NEWSWIRE) — Arteris, Inc. (Nasdaq: AIP), a leading provider of system IP which accelerates system-on-chip (SoC) creation, today announced that it has joined the broad-market Russell 2000® Index. “We are excited to be included in the Russell 2000® Index. This milestone is a testament to the dedication and hard work of our team, as well as the continued support of our shareholders and stakeholders. Inclusion in the Russell 2000® Index not only validates our growth trajectory but also enhances our visibility among investors and strengthens our position as a leader in the semiconductor IP industry. We remain committed to delivering cutting-edge solutions for the increasingly complex SoC design environment and driving value for our stakeholders as the industry increasingly shifts towards merchant...

SLR Investment Corp. Schedules the Release of its Financial Results for the Quarter Ended June 30, 2024

Written by Customer Service on July 1, 2024. Posted in Public Companies.

NEW YORK, July 01, 2024 (GLOBE NEWSWIRE) — SLR Investment Corp. (the “Company”) (NASDAQ: SLRC) today announced that it will release its financial results for the quarter ended June 30, 2024 on Wednesday, August 7, 2024 after the close of the financial markets. The Company will host an earnings conference call and audio webcast at 10:00 a.m. (Eastern Time) on Thursday, August 8, 2024. All interested parties may participate in the conference call by dialing (800) 267-6316 approximately 5-10 minutes prior to the call, international callers should dial (203) 518-9783. Participants should reference SLR Investment Corp. and Conference ID: SLRC2Q24. A telephone replay will be available until August 22, 2024 and can be accessed by dialing (800) 839-2418. International callers should dial (402) 220-7210. This conference call will also be...

Corza Medical Completes Acquisition of TachoSil Manufacturing Operations

Written by Customer Service on July 1, 2024. Posted in Mergers And Acquisitions.

Corza Medical Completes Acquisition of TachoSil Manufacturing Operations in Linz, Austria Corza Medical is a leading global manufacturer of innovative surgical technologies. With a global team of over 3,000 employees supporting clinicians, distributor-partners, and medical device companies worldwide, Corza provides healthcare professionals a platform of surgical technologies with many industry-leading brands, including Quill® barbed sutures, Sharpoint® Plus and Look™ surgical sutures, Katena® reusable and Blink™ single-use ophthalmic instruments, Barron corneal transplant devices, Sharpoint® microsurgical knives, and the TachoSil® fibrin sealant patch. For more information, please visit www.corza.com. WESTWOOD, Mass., July 01, 2024 (GLOBE NEWSWIRE) — Corza Medical successfully closed its previously announced...

Dragonfly Energy Powers Pepsi Deliveries Sustainably and Reliably With New Liftgate Battery Systems

Written by Customer Service on July 1, 2024. Posted in Public Companies.

Battle Born Batteries Powering Liftgate Operations for Refreshment Services Pepsi Battle Born Batteries Powering Liftgate Operations for Refreshment Services Pepsi Refreshment Services Pepsi, an independent bottler and distributor for Pepsi-Cola products, is transitioning to Dragonfly Energy’s Battle Born Batteries® to power liftgate operations within its fleet. Compared to traditional lead-acid batteries, lithium-ion technology provides Refreshment Services Pepsi with significant cost savings and environmental advantages, including fewer battery replacements, fuel savings, reduced downtime, and a longer lifespan. This partnership highlights Dragonfly Energy’s ongoing growth in the medium and heavy-duty trucking industry and the expansion of its product offerings in the market. RENO, Nev., July 01, 2024 (GLOBE NEWSWIRE)...

Watsco Declares $2.70 Quarterly Dividend

Written by Customer Service on July 1, 2024. Posted in Public Companies.

MIAMI, July 01, 2024 (GLOBE NEWSWIRE) — Watsco, Inc.’s (NYSE: WSO) Board of Directors has declared a regular quarterly cash dividend of $2.70 on each outstanding share of its Common and Class B common stock payable on July 31, 2024 to shareholders of record at the close of business on July 16, 2024. Watsco has paid dividends to shareholders for 50 consecutive years. The Company’s philosophy is to share cash flow through dividends while maintaining a conservative balance sheet with continued capacity to build its distribution network. Future changes in dividends are considered in light of investment opportunities, cash flow, general economic conditions and Watsco’s overall financial condition. About Watsco Watsco operates the largest distribution network for heating, air conditioning and refrigeration (HVAC/R) products with locations...

Day: July 1, 2024

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Cookie Notice